Another trouble for J&J: CDSCO seize samples of baby products for testing Farhat Nasim22 Dec 2018 12:14 PM ISTThe action by CDSCO has come at a time when the company is already embroiled in a controversy over its faulty hip implants. New Delhi: Following...
Novartis appoints Susanne Schaffert as new CEO of Oncology Business Unit Farhat Nasim22 Dec 2018 9:35 AM ISTSusanne Schaffert will report to Vas Narasimhan, CEO, Novartis, and will join the Executive Committee on January 1, 2019.New Delhi: Swiss pharma giant...
Sun Pharma arm gets USFDA nod for Elepsia XR, an antiepileptic drug Farhat Nasim22 Dec 2018 9:30 AM ISTThe United States Food and Drug Administration (USFDA) has granted approval for the New Drug Application to a wholly-owned subsidiary of Sun Pharma...
Bristol-Myers gets more than Rs 1000 crore offer from Taisho Pharma Farhat Nasim22 Dec 2018 9:15 AM ISTUpon exercise of the put option, Taisho would acquire UPSA as well as Bristol-Myers Squibb's assets and liabilities relating to the UPSA product...
CDSCO tightens safety and labelling rules for ISOTRETINOIN,prescription of dermatologist mandatory Farhat Nasim21 Dec 2018 1:06 PM ISTIn light of concerns raised regarding Isotretinoin, the matter has been examined by CDSCO in consultation with the Subject Expert Committee...
Seperate Bills for Hospital Services, Medicines: Proposal with GST Council Farhat Nasim21 Dec 2018 11:40 AM ISTNew Delhi: The Goods and Services Tax (GST) council is all set to give a dose of tax by demanding to unbundle the bills raised by healthcare delivery...
3.36% of about 82,600 drugs samples found to be substandard Farhat Nasim21 Dec 2018 10:00 AM ISTOf the total, 236 drugs samples or 0.28 per cent were declared spurious or adulterated, Minister of State Chemicals and Fertilisers Mansukh L...
AstraZeneca gets USFDA nod for LYNPARZA as maintenance treatment Medical Dialogues Bureau21 Dec 2018 9:33 AM ISTThe approval was based on positive results from a late-stage study in which the drug, Lynparza, reduced the risk of disease progression or death by 70...
Strides to get approx Rs 2.95 billion after Mylan's claims over Agila sale get rejected Farhat Nasim21 Dec 2018 9:31 AM ISTStrides Pharma Science and its wholly-owned subsidiary completed the sale to Mylan Laboratories and Mylan Institutional of Agila Specialties Private...
Indivior to launch Sublocade; maintains revenue forecast Medical Dialogues Bureau21 Dec 2018 9:00 AM ISTIndivior also said revenue from its new opioid addiction treatment, Sublocade, would exceed the top end of its previous 2018 forecast range of $8...
Asbestos scare: CDSCO draws samples of J&J baby powder from HP plant Medical Dialogues Bureau20 Dec 2018 5:12 PM ISTThe CDSCO, under the Union Health Ministry, said over the next four to five days, drug inspectors will search manufacturing plants and wholesalers of...
China first to approve AstraZeneca, FibroGen Roxadustat Medical Dialogues Bureau20 Dec 2018 9:16 AM ISTRoxadustat is the first of a new kind of oral anaemia treatment called a hypoxia-inducible factor prolyl hydroxylase inhibitor that boosts production...
